Stay updated on Pembrolizumab in NK/T & EBV+ DLBCL: Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab in NK/T & EBV+ DLBCL: Clinical Trial page.
![Latest website image capture](/pages/_next/image?url=https%3A%2F%2Fs3.us-west-2.amazonaws.com%2Fvp-files-ore%2Fresources%2F12months%2F65O8Twcten4aupt3WYS4xAFAWXw.uncropped.jpg&w=3840&q=75)
Latest updates to the Pembrolizumab in NK/T & EBV+ DLBCL: Clinical Trial page
- Check4 days agoChange DetectedDifference0.7%
- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedThe website has been updated from version 2.10.0 to 2.10.2, indicating new features or improvements in the latest release.SummaryDifference0.8%
- Check25 days agoNo Change Detected
- Check32 days agoNo Change Detected
- Check33 days agoChange DetectedDifference0.7%
- Check37 days agoChange DetectedDifference1%
- Check39 days agoChange DetectedDifference1%
- Check40 days agoChange DetectedThe study has been updated to version v2.10.0, replacing the previous version v2.9.7.SummaryDifference0.5%
Stay in the know with updates to Pembrolizumab in NK/T & EBV+ DLBCL: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in NK/T & EBV+ DLBCL: Clinical Trial page.